Tenmile is an Australian health technology venture capital firm backed by Tattarang, investing in biotech, medtech, and digital health companies. It focuses on early-stage companies from seed through commercialization, aiming to connect Australian innovation to global markets.
Average disclosed round size is $68.4M (across 12 rounds with reported amounts).
Portfolio
12
Fund Size
$173.6M
Top Stage
Unknown
Last 12 Mo
0
Team
Portfolio Breakdown
Stage Distribution
Sector Distribution
Investment Activity
DealsAvg Round Size
Portfolio
15 investments
| Company | Round | Amount | Date |
|---|---|---|---|
| LLimmaTech Biologics AG | Series A | $37M | Oct 2023 |
| LLimmaTech Biologics AG | Series A | $37M | Jan 2023 |
 Aravax | Series B | $42.2M | Jan 2022 |
| CCarina Biotech | Unknown | $7.5M | Jan 2022 |
 Mindset Health | Seed | $1.1M | Nov 2019 |
 AdvanCell | Series D | $315M | — |
 Syndeio Biosciences | Unknown | $90M | — |
| AAntares Therapeutics | Series A | $177M | — |
 Psylo | Seed | $5M | — |
 Proton Intelligence | Seed | $7.0M | — |
| SSyndeio | Unknown | $90M | — |
| KKantoko | Seed | — | — |
| CCurveBeam AI | Unknown | — | — |
| Mindset Health | Series A | $12M | — |
| AdvanCell | Bridge | — | — |
Top Co-Investors
Catalio Capital Management4 shared
Eli Lilly and Company4 shared
Abingworth LLP3 shared
Brandon Capital3 shared
Palo Santo3 shared
Sanofi Ventures2 shared
Eventide Asset Management2 shared
T. Rowe Price2 shared
Alpha Wave Global2 shared
SV Health Investors2 shared
Time BioVentures2 shared
Fidelity Investments2 shared
Morningside2 shared
SymBiosis2 shared
Ally Bridge Group2 shared
Bain Capital Life Sciences2 shared
AbbVie2 shared
ARCH Venture Partners2 shared
British International Investment2 shared
AXA IM Alts2 shared
Last updated: 20 October 2026